Avanos Medical, Inc. (NYSE:AVNS) will be discussing 2Q20 financial results with the investment community.on 4th August 2020 at 9:00 AM eastern time.
Those interested in listening to the conference call live via the Internet can visit avanos.com
Earnings Expectation
Avanos Medical, Inc. is reporting second quarter financial results on Tuesday 4th August 2020, before market open.
According to analysts surveyed by Thomson Reuters, AVNS is expected to report 2Q20 loss of $ 0.1 per share from revenue of $ 147.90 million.
For the full year, analysts anticipate top line of $ 667.92 million, while looking forward to income of $ 0.37 per share bottom line.
The Company Outlook
Full Year 2020 topline are forecasted in a range of$ 732.48 million ~ $ 746.43 million, where as bottomline are predicted in a range of $ 1.00 ~ $ 1.20 per share
Click Here For More Historical Outlooks Of Avanos Medical, Inc.
Avanos Medical, Inc. operates as a medical technology company that focuses on delivering medical device solutions to improve patients quality of life worldwide. It provides a portfolio of products focuses on respiratory and digestive health; pain management solutions; and minimally invasive interventional pain therapies, closed airway suction systems, and enteral feeding tubes.
